# Stem Cell Injection to Treat Heart Damage During Open Heart Surgery

> **NCT01557543** · PHASE1 · TERMINATED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 24 (actual)

## Conditions studied

- Heart Disease
- Ischemic Heart Disease
- Coronary Artery Disease
- Coronary Artery Disease (CAD)

## Interventions

- **OTHER:** Cell Therapy

## Key facts

- **NCT ID:** NCT01557543
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-02-29
- **Primary completion:** 2017-07-25
- **Final completion:** 2018-06-18
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2018-07-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01557543

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01557543, "Stem Cell Injection to Treat Heart Damage During Open Heart Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01557543. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*